Cargando…

Primary Vasculitis in Childhood: GPA and MPA in Childhood

Childhood onset anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a rare group of primary systemic vasculitides affecting medium and small blood vessels. AAV includes granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jariwala, Mehul P., Laxer, Ronald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107029/
https://www.ncbi.nlm.nih.gov/pubmed/30167431
http://dx.doi.org/10.3389/fped.2018.00226
_version_ 1783349897762701312
author Jariwala, Mehul P.
Laxer, Ronald M.
author_facet Jariwala, Mehul P.
Laxer, Ronald M.
author_sort Jariwala, Mehul P.
collection PubMed
description Childhood onset anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a rare group of primary systemic vasculitides affecting medium and small blood vessels. AAV includes granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal limited ANCA vasculitis. These disorders are associated with severe clinical manifestations, frequent relapses and a high cumulative morbidity, and often present with multisystem involvement. Renal involvement is common in the pediatric age group, characterized by pauci-immune necrotizing and crescentic glomerulonephritis which frequently progresses to chronic kidney disease in adulthood. ANCAs against proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO) (MPO-ANCA) remain the hallmark of AAV and are integral to the disease pathogenesis. Newer understanding of neutrophil extracellular traps and complement activation have provided better insights into disease pathogenesis. A pediatric vasculitis working group has developed and validated childhood vasculitis classification criteria and disease activity and damage scores. No specific pediatric treatment recommendations exist due to rare nature of the illness in pediatric population. Smaller case series have been published on the efficacy of adult treatment regimens in pediatric patients. The prognosis often remains guarded with frequent relapses and a high cumulative morbidity. The aim of this article is to provide a comprehensive review on pediatric AAV with a focus on recent observations regarding epidemiology, disease pathogenesis, treatment, and prognosis.
format Online
Article
Text
id pubmed-6107029
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61070292018-08-30 Primary Vasculitis in Childhood: GPA and MPA in Childhood Jariwala, Mehul P. Laxer, Ronald M. Front Pediatr Pediatrics Childhood onset anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a rare group of primary systemic vasculitides affecting medium and small blood vessels. AAV includes granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal limited ANCA vasculitis. These disorders are associated with severe clinical manifestations, frequent relapses and a high cumulative morbidity, and often present with multisystem involvement. Renal involvement is common in the pediatric age group, characterized by pauci-immune necrotizing and crescentic glomerulonephritis which frequently progresses to chronic kidney disease in adulthood. ANCAs against proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO) (MPO-ANCA) remain the hallmark of AAV and are integral to the disease pathogenesis. Newer understanding of neutrophil extracellular traps and complement activation have provided better insights into disease pathogenesis. A pediatric vasculitis working group has developed and validated childhood vasculitis classification criteria and disease activity and damage scores. No specific pediatric treatment recommendations exist due to rare nature of the illness in pediatric population. Smaller case series have been published on the efficacy of adult treatment regimens in pediatric patients. The prognosis often remains guarded with frequent relapses and a high cumulative morbidity. The aim of this article is to provide a comprehensive review on pediatric AAV with a focus on recent observations regarding epidemiology, disease pathogenesis, treatment, and prognosis. Frontiers Media S.A. 2018-08-16 /pmc/articles/PMC6107029/ /pubmed/30167431 http://dx.doi.org/10.3389/fped.2018.00226 Text en Copyright © 2018 Jariwala and Laxer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Jariwala, Mehul P.
Laxer, Ronald M.
Primary Vasculitis in Childhood: GPA and MPA in Childhood
title Primary Vasculitis in Childhood: GPA and MPA in Childhood
title_full Primary Vasculitis in Childhood: GPA and MPA in Childhood
title_fullStr Primary Vasculitis in Childhood: GPA and MPA in Childhood
title_full_unstemmed Primary Vasculitis in Childhood: GPA and MPA in Childhood
title_short Primary Vasculitis in Childhood: GPA and MPA in Childhood
title_sort primary vasculitis in childhood: gpa and mpa in childhood
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107029/
https://www.ncbi.nlm.nih.gov/pubmed/30167431
http://dx.doi.org/10.3389/fped.2018.00226
work_keys_str_mv AT jariwalamehulp primaryvasculitisinchildhoodgpaandmpainchildhood
AT laxerronaldm primaryvasculitisinchildhoodgpaandmpainchildhood